Green Thumb Industries Inc. (OTCMKTS:GTBIF - Free Report) - Research analysts at Roth Capital lowered their Q3 2025 EPS estimates for Green Thumb Industries in a research report issued to clients and investors on Thursday, August 7th. Roth Capital analyst W. Kirk now forecasts that the company will post earnings per share of $0.01 for the quarter, down from their previous estimate of $0.05. The consensus estimate for Green Thumb Industries' current full-year earnings is $0.32 per share. Roth Capital also issued estimates for Green Thumb Industries' Q4 2025 earnings at $0.02 EPS, Q1 2026 earnings at $0.02 EPS, Q2 2026 earnings at $0.03 EPS, Q3 2026 earnings at $0.02 EPS and Q4 2026 earnings at $0.02 EPS.
Green Thumb Industries Price Performance
Shares of Green Thumb Industries stock traded up $0.15 on Friday, hitting $7.13. The company had a trading volume of 601,513 shares, compared to its average volume of 631,384. The firm has a market capitalization of $1.51 billion, a P/E ratio of 64.82 and a beta of 1.18. Green Thumb Industries has a twelve month low of $4.63 and a twelve month high of $12.00. The stock has a 50-day moving average of $5.70 and a 200-day moving average of $5.99.
Green Thumb Industries (OTCMKTS:GTBIF - Get Free Report) last posted its earnings results on Wednesday, August 6th. The company reported ($0.01) earnings per share for the quarter, missing the consensus estimate of $0.04 by ($0.05). The firm had revenue of $293.26 million during the quarter, compared to analyst estimates of $280.66 million. Green Thumb Industries had a return on equity of 1.62% and a net margin of 2.51%.
Green Thumb Industries Company Profile
(
Get Free Report)
Green Thumb Industries Inc manufactures, distributes, markets, and sells of cannabis products for medical and adult-use in the United States. It operates through two segments, Retail and Consumer Packaged Goods. The company offers cannabis flower; processed and packaged products, including pre-rolls, concentrates, vapes, capsules, tinctures, edibles, topicals, and other cannabis-related products under the &Shine, Beboe, Dogwalkers, Doctor Solomon's, Good Green, incredibles, and RHYTHM brands.
Featured Stories
Before you consider Green Thumb Industries, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Green Thumb Industries wasn't on the list.
While Green Thumb Industries currently has a Strong Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
